Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date CCAB: CCAB: Addressing the risk of microbial impurities... Dr Friedrich von Wintzingerode, QC Lead iNeST, Roche and Nahuel Paolini, PhD, Sanquin Reagents Full Title: CCAB: Addressing the risk of microbial impurities in Biologics and certain Advanced Therapy Medicinal Products (ATMPs) For parenteral dr... 1 year ago | 69 mins New Tools to Assess the Risk of Microbial Impurities in the Pharmaceutical... Presented by Friedrich von Wintzingerode Global QC at Roche Followed by Mathilde Arnault, Research Scientist at Merck KGaA, Full Title: New Tools to Assess the Risk of Microbial Impurities in the Pharmaceutical Manufacturing Process Large scale Production of Biologics is s... 4 years ago | 62 mins A Comprehensive Approach to Assess the Impact of Microbial Impurities on Pat... Dr Friedrich von Wintzingerode, QC Lead iNeST Project at Roche and Shabnam Solati, CEO & Co-Founder at CTL-MAT FULL TITLE: A Comprehensive Approach to Assess the Impact of Microbial Impurities on Patient Safety and Product Quality of Biologics Presented by Dr ... 3 years ago | 80 mins
